This inventor holds 1 USPTO granted patent. Top assignee: Isp Investments Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of David Berry
Introduction
David Berry is an accomplished inventor based in Eaglescliffe, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on small-molecule povidone analogs. His expertise and dedication to research have led to the development of valuable pharmaceutical technologies.
Latest Patents
David Berry holds a patent for "Small-molecule povidone analogs in coamorphous pharmaceutical phases." This patent describes an amorphous dispersion that comprises bis(vinylcaprolactam) and an active pharmaceutical ingredient. His work in this area demonstrates his commitment to advancing pharmaceutical formulations.
Career Highlights
Throughout his career, David has been associated with Isp Investments Inc., where he has contributed to various research initiatives. His innovative approach and technical skills have positioned him as a key player in the pharmaceutical industry.
Collaborations
David Berry has collaborated with notable colleagues, including Osama M Musa and Jonathan W Steed. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
David Berry's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile